🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Chengzi I. Kaku

Scripps Research Institute

ORCID: 0000-0002-9854-8351

Also affiliated with Scripps Institution of Oceanography, Scripps (United States), Adimab (United States)

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 9 papers. Top paper: “Prolonged evolution of the human B cell response to SARS-CoV-2 infection”.

Prolonged evolution of the human B cell response to SARS-CoV-2 infection

Science Immunology(2021)10.1126/sciimmunol.abg6916

N/A

6.4DataRank · unranked

201 citations

C. Garrett Rappazzo, Wendy Wieland‐Alter, Ching‐Lin Hsieh, Daniel Wrapp, Emma S. Esterman +8 more

An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.11.17.385500

N/A

0.457DataRank · unranked

20 citations

Longping V. Tse, Chengzi I. Kaku, Daniel Wrapp, Mrunal Sakharkar, Deli Huang +21 more

Characteristics and Functions of Infection-enhancing Antibodies to the N-terminal Domain of SARS-CoV-2

Pathogens and Immunity(2024)10.20411/pai.v9i2.679

N/A

0.292DataRank · unranked

6 citations

Mrunal Sakharkar, Garrett Rappazzo, Chengzi I. Kaku, Nicholas C. Curtis, Seungmin Shin +9 more

A recurring YYDRxG pattern in broadly neutralizing antibodies to a conserved site on SARS-CoV-2, variants of concern, and related viruses

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.15.472864

N/A

0DataRank · unranked

8 citations

Chengzi I. Kaku, Ge Song, Meng Yuan, Raiees Andrabi, Dennis R. Burton +3 more

Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including Omicron

Communications Biology(2022)10.1038/s42003-022-03700-6

N/A

0DataRank · unranked

31 citations

Chengzi I. Kaku, Ge Song, Meng Yuan, Raiees Andrabi, Dennis R. Burton +3 more

Revisiting an IgG Fc Loss-of-Function Experiment: the Role of Complement in HIV Broadly Neutralizing Antibody b12 Activity

mBio(2021)10.1128/mbio.01743-21

N/A

0DataRank · unranked

10 citations

Chengzi I. Kaku, Jérémy Dufloo, Timothée Bruel, Olivier Schwartz, David A. Spencer +3 more

Targeting peptide antigens using a multiallelic MHC I-binding system

Nature Biotechnology(2024)10.1038/s41587-024-02505-8

N/A

0DataRank · unranked

26 citations

Leena Mallik, Daniel Hwang, Yi Sun, Chengzi I. Kaku, Daniel Hoces +24 more

Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody

Science(2021)10.1126/science.abf4830

N/A

0DataRank · unranked

392 citations

Longping V. Tse, Chengzi I. Kaku, Daniel Wrapp, Mrunal Sakharkar, Deli Huang +22 more

Characteristics and functions of infection-enhancing antibodies to the N-terminal domain of SARS-CoV-2

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.19.558444

N/A

0DataRank · unranked

3 citations

Mrunal Sakharkar, C. Garrett Rappazzo, Chengzi I. Kaku, Nicholas C. Curtis, Seungmin Shin +7 more